Herlev

• INVITED trial Recruiting
  2022-500906-17-01 4 2023-03-21 Type 1 diabetes
• A phase 2 trial on propranolol in combination with pembrolizumab in advanced Angiosarcoma and Undifferentiated Pleomorphic Sarcoma Recruiting
  2024-513727-16-00 4 2022-12-05 Advanced Angiosarcoma and Undifferentiated Pleomorphic Sarcoma
• A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients with Metastatic Colorectal Cancer (INTRINSIC) Recruiting
  2023-505163-37-00 3 2021-10-01 Metastatic Colorectal Cancer
• Treatment of adynamic bone disorder with parathyroid hormone in patients with chronic kidney disease Recruiting
  2023-506853-39-00 6 2021-05-20 Adynamic bone disorder
• Electrochemotherapy versus standard radiotherapy for the treatment of basal cell carcinoma Recruiting
  2024-519066-49-01 6 2020-11-16 Basal cell carcinoma (non-melanoma skin cancer)
• The DENOCHARCOT trial. Efficacy of treatment with DENOsumab of an acute CHARCOT foot in patients with diabetes. A multicenter, double-blind, … Recruiting
  2024-515365-34-00 6 2020-11-01 diabetic acute Charcot foot (Charcot neuroarthropathy)
• FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma Recruiting
  2024-510579-40-00 9 2020-10-07 Rhabdoyosarcoma
• ProTarget - A Danish Nationwide Clinical Trial on Targeted Anti‐Cancer Treatment based on Genomic Profiling Recruiting
  2023-510527-29-00 4 2020-09-01 Cancer
• An exploratory, randomized, double-blind, multicenter, placebo-controlled study to assess the safety, tolerability, pharmacokinetics, and ef … Recruiting
  2024-518384-36-00 4 2020-08-31 Idiopathic membranous nephropathy and severe proteinuria
• Goal directed fluid removal in critically ill patients with fluid overload Recruiting
  2024-512186-14-00 6 2020-08-24 Fluid overload/fluid accumulation
• Phase 1/2a Open-Label, Dose-Escalation, Multicenter, First-in-Human, Consecutive-Cohort, Clinical Trial of BI-1808, a Monoclonal Antibody to … Recruiting
  2023-509847-29-00 7 2020-04-09 Advanced solid tumors
• Impact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy Recruiting
  2024-517854-91-00 5 2019-08-05 Metastatic or high-risk recurrent prostate cancer managed with androge
• Efficacy of immunotherapy in melanoma patients with brain metastases treated with steroids. The MEMBRAINS trial Recruiting
  2024-516585-11-00 4 2018-06-12 Advanced melanoma
• Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365) Recruiting
  2023-506987-15-00 9 2016-11-17 Metastatic Castration-Resistant Prostate Cancer
• rEECur: International Randomised Controlled Trial of Chemotherapy for the Treatment of Recurrent and Primary Refractory Ewing Sarcoma Recruiting
  2024-516078-31-00 10 2015-05-05 Recurrent and Primary Refractory Ewing Sarcoma
• A multi-part, adaptive, Phase 1, first time in human study in healthy participants and participants with atopic dermatitis (AD) to assess th … Ended recruitment
  2025-522216-17-00 1 2026-01-26 Atopic Dermatitis
• Safety and Efficacy of AT-004 in Patients with Acne Vulgaris Ended recruitment
  2025-521510-25-00 4 2026-01-13 Acne vulgaris
• A study of BMS-986504 in combination with Nab-p/Gem versus placebo in combination with Nab-p/Gem in untreated metastatic PDAC with homozygou … Ended recruitment
  2025-522598-12-00 10 2025-12-17 Untreated Metastatic Pancreatic Ductal Adenocarcinoma
• Safety, Tolerability and Biomarker-based Efficacy of NPI-001 (AT-001) in Subjects with Alzheimer’s Disease (AD) Ended recruitment
  2024-519497-39-00 4 2025-10-03 Alzheimer's Disease
• A Study to Find Out How Safe and Effective AZD0780 Is for Adults with High 'Bad' Cholesterol from an Inherited Condition Ended recruitment
  2025-520520-17-00 5 2025-09-05 Heterozygous familial hypercholesterolaemia
• A Study of Tirzepatide (LY3298176) Compared with Placebo in Adults with Type 1 Diabetes and Obesity or Overweight (SURPASS-T1D-1) Ended recruitment
  2024-519684-17-00 5 2025-06-23 Obesity
• Efficacy and Safety of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight (MA … Ended recruitment
  2024-515524-36-00 5 2025-05-30 Chronic Weight Management
• Phase 2 Pan-Tumor Trial of R-DXd for Advanced/Metastatic Solid Tumors Ended recruitment
  2024-513307-13-00 4 2025-05-26 Advanced/metastatic solid tumors including gynecological cancers (endo
• A Phase 3 Study Comparing BMS-986365 versus Investigator’s Choice of Therapy in Participants with Metastatic Castration-resistant Prostate C … Ended recruitment
  2024-517422-25-00 5 2025-05-22 Metastatic Castration-resistant Prostate Cancer (mCRPC)

Showing 145–168 of 296 trials